bpc-157 fda warning FDA's Overreach on Compounded Peptides BPC-157 FDA Approval Status: Is

Researchers propose that the peptide's brief presence is sufficient to trigger a cascade of gene expression changesincluding activation of transcription factors c-Fos, c-Jun, and Egr-1that initiate self-sustaining healing processes well beyond the peptide's physical presence

doi:10.1016/j.pbi.2007.04.009

Often called the Wolverine peptide because of its rapid healing reputation, BPC-157 has become one of the most searched, studied, and discussed regenerative peptides in the world of integrative medicine, sports recovery, and longevity science

The appeal is obvious: Peptides that can cost hundreds of dollars per vial cost a fraction as much